Introduction

27
Helical membrane proteins constitute roughly a quarter of the proteome in all 28 organisms 1 and are responsible for essential and diverse biological functions. Their prototypical 29 primary sequence is characterized by stretches of hydrophobic sequence that form 30 transmembrane helices (TMHs), separated by hydrophilic loops of varying lengths that protrude 31 from both sides of the membrane. Their hydrophobic nature makes them aggregate quickly in 32 aqueous solutions, necessitating their cotranslational insertion into the membrane. In this way, 33 aggregation is avoided by sequential insertion of the individual TMHs as they are synthesized by 34 the ribosome-translocon complex 2 . This cotranslational insertion sets the initial topology of the 35 protein. Once inserted, it is typically assumed that the topology of a membrane protein cannot 36 change anymore, mainly because any topological change would require the unfavorable 37 transfer of hydrophilic loops through the membrane. Thus, membrane proteins are believed to 38 follow a strict two-stage 2,3 biogenesis mechanism: in the first stage, the protein 39 cotranslationally inserts into the membrane and assumes its final, stable topology. In the 40 second stage, the inserted TMHs pack together to form the final three-dimensional functional 41
fold. 42
In recent years, however, several cases where topological dynamics does occur have 43 been described. Some specialized proteins, such as bacteriophage holins and other pore-44 forming proteins, have evolved to switch topology when triggered by a physiological cue [4] [5] [6] . In 45 other cases, topological dynamics was observed only under artificial conditions where, e.g., the 46 lipid composition of the membrane was dramatically altered 7, 8 , or the protein had to be 47 truncated or mutated to observe dynamics [9] [10] [11] [12] [13] . It remains unclear, however, if natural 48 membrane proteins can display topological dynamics under physiological conditions and, if so, 49 how such phenomena would affect the folding routes taken by membrane proteins in vivo. The 50 biophysical principles underlying topological dynamics are also poorly understood. 51
Here we show that EmrE, a dimeric inner membrane protein from Escherichia coli, is 52 topologically dynamic in its pre-assembled monomeric state in vivo. We find that, in monomeric 53
EmrE, the N-terminal TMH1 flips in and out of the membrane, while dimeric EmrE has a stable 54 membrane topology. We characterize the kinetics of the process and show how changes in the 55 3 composition of TMH1 affect the rate of the topological dynamics. Our study suggests that 56 membrane proteins may exist in a dynamic equilibrium between different topological states, 57 and contributes to our understanding of how protein composition determines topology. 58
59
Results
60
The N-terminus of monomeric EmrE is partially mislocalized 61
EmrE is an E. coli homodimeric multidrug transporter, composed of two 4-TMH 62 monomers 14 . It belongs to a unique group of proteins characterized by dual topology, where 63 the monomer inserts into the membrane with two opposite orientations with equal 64 probabilities [15] [16] [17] [18] . The oppositely-oriented monomers then assemble to form the functional 65 antiparallel dimer 16, 17 . It has recently been shown that the dual topology of EmrE is generated 66 early during biosynthesis when the monomers are inserted 18 , and that the overall orientations 67 of monomers in the membrane are stable thereafter 19 . 68
Here, we studied the detailed topology of EmrE using a cysteine-accessibility assay. 69
Briefly, the assay works by assessing the level of cysteine accessibility towards a periplasmic 70 reagent (Fig. 1a) 19 . We engineered single Cys mutations in all loops and the two terminal tails of 71 EmrE (Fig. 1b) ; all Cys mutants remained functional ( Supplementary Fig. 1 ). We also tested the 72 localization of the same loops/tails in well-characterized EmrE mutants engineered to insert 73 with a single topology, either Nout/Cout or Nin/Cin, in which both termini are located in the 74 periplasm or cytoplasm, respectively (Fig. 1c, top) . The Nout/Cout and Nin/Cin single-topology 75 mutants cannot form the functional antiparallel dimer unless co-expressed 17, 18, 20 . To determine 76 the locations of the individual cysteines relative to the membrane, cells were subjected to a 20 77 min reaction with AMS, a reagent that cannot cross the plasma membrane and therefore blocks 78 only periplasmically accessible cysteines 19, 21 (Fig. 1a) . The unblocked, cytosolic cysteines can 79 later be reacted with maleimide-PEG, resulting in a shift in gel-migration. The results are 80 quantified as fraction of AMS-blocked protein, reporting on the fraction of molecules that 81 exposed the test Cys to the periplasm (see Supplementary Fig. 2) . 82
For almost all positions, the results agree with the expected topology, namely the 83 cysteines alternate between nearly full blocking or inaccessibility from the periplasm in the 84 6 intracellularis (names given are Uniprot accessions). Both proteins were shown before to have a 139
Nin/Cin topology and to dimerize with a Nout/Cout partner of the SMR family that is encoded by a 140 separate gene in their respective operons 19 . We introduced a reporter Cys in the cytosolic N 141 terminus of both proteins and followed its periplasmic blocking by AMS over time. When co-142 expressed with their partner, both proteins showed a stable cytosolic location of the N 143 terminus (Fig. 3 c,d ). In contrast, when expressed alone, both proteins showed elevated 144 periplasmic exposure. The periplasmic exposure of Q1MPU8 occurred quite slowly (30% over 145 the dimer during 80 minutes Fig. 3 c) , whereas that of B8J442 was apparently so rapid that it 146 was predominantly blocked already at the 1 min time point (Fig. 3 d) . Thus, monomers of the 147 SMR family may frequently have a dynamic topology and dimerization is needed to achieve a 148 stable, fully integrated state. 149
150
Determinants of TMH1 insertion dynamics 151
What makes TMH1 dynamic while the other TMHs of EmrE remain fixed? A major 152 barrier for topological dynamics is presumably the energetically costly transfer of hydrophilic 153 extramembrane tail and loop regions across the membrane interior 22 . Indeed, the rate of N-154 terminal flipping in the three proteins that we have tested seems to correlate inversely with the 155 length of the N-terminal hydrophilic tail. B8J442, which shows very fast periplasmic blocking, 156 does not have a hydrophilic N-terminal tail at all, the exceedingly slowly blocked Q1MPU8 has a 157 substantially longer hydrophilic tail, and EmrE has a short tail with only three residues, MNP, 158 preceding the hydrophobic TMH1 (see sequences in Fig. 3b,c,d ). To directly test the influence of 159 the tail, we extended the N-terminus of EmrE[Nin/Cin-P 3 C] by one, two, or three serines. Indeed, 160 the hydrophilic extensions gradually slowed the dynamics, nearly completely abolishing it 161 already at two serines (Fig. 4a) . Addition of serines also increased the fraction of membrane-162 inserted TMH1 at t = 0 (as indicated by the low level of blocking of the N terminus). This 163 suggests that TMH1 is actually hydrophobic enough to get efficiently inserted into the inner 164 membrane during the cotranslational insertion step (see later). 165 We next wondered how the hydrophobicity of the membrane-embedded part of TMH1 166 may affect the dynamics. Making TMH1 more hydrophobic by one or two mutations gradually7 decreased the topological dynamics, while hydrophilic mutations had the opposite effects (Fig.  168 4b). Strikingly, ln(k1) was found to be directly proportional to the hydrophobicity of TMH1 as 169 measured by the biological hydrophobicity scale 23 ( Supplementary Fig. 6 ). This suggests that the 170 activation energy for the transition from the transmembrane to the periplasmically exposed state 171 of TMH1 scales with its hydrophobicity. Collectively, it seems that hydrophilicity exerts opposite 172 effects on the topological dynamics from within the TMH or outside of it: a hydrophilic loop slows 173 topological dynamics, whereas a hydrophilic TMH accelerates it. 174
One puzzling observation was that even the most hydrophillic TMH1 mutants appear to be well 175 inserted at t = 0, when the blocking reaction is initiated (Fig. 4b) . This contradicted our 176 expectation that hydrophilic TMH1 mutants will not be well inserted into the membrane. The existence of topological dynamics in monomeric EmrE demonstrates that 214 membrane protein topology is not necessarily fixed after the cotranslational membrane-215 insertion step. This has implications for the folding and quality control routes taken by 216 membrane proteins. For example, marginally hydrophobic transmembrane helices may have a 217 chance to integrate post-translationally if they were missed during cotranslational insertion. 218
Protein folding can perhaps even drive membrane insertion of such TMHs. A dynamic, mis-219 inserted state may be a hallmark of unfolding and perhaps also serve as a recognition 220 determinant for cellular quality control 26 . 221
Membrane protein folding has traditionally been separated into two stages: TMH 222 insertion and packing 3 . This in turn has simplified the description of the 'second stage' of 223 folding, at which the already inserted helices pack together [27] [28] [29] [30] . Current models assuming that 224 the topology is completely fixed may need to accommodate more degrees of topological 225 9 freedom of the unfolded state 22, 31 . In that respect, better understanding of how common these 226 phenomena are is crucial. Our analysis cannot yet answer this question but it can provide some 227 hints. On the one hand, we observed topological dynamics in all three EmrE homologs tested, 228
suggesting that it may not be extremely rare. On the other hand, out of the four TMHs of EmrE, 229 only TMH1 is dynamic. The topological dynamics that we observe depends on the hydrophilicity 230 of the TMH and its flanking tail. The short and not very polar N-terminal tail and the relatively 231 weak hydrophobicity of EmrE TMH1 are not unusual among other TMHs in the E. coli inner-232 membrane proteome (Fig. 5a,b) , but the combination of these two features makes EmrE TMH1 233 stand out (Fig. 5c) proteins of interest were grown in M9 minimal medium at 37°C to mid-log phase (OD600 ~0.5). 259
The cultures were then induced by 0.1 mM IPTG for 10 min, followed by 15 min incubation with 260 0.2 mg/ml rifampicin, during shaking at 37°C. Proteins were labeled with 15 μCi [
35 S]Met, 261 typically for 5 min, then mixed with a high excess (2 mM) of non-radioactive methionine for 262 variable chase times and put on ice for 5 min to stop the reaction. The chase was typically 5 263 min, except for Fig 1c, Supplementary Fig. 3 and Supplementary Fig. 2 , where the chase time 264 was 0 min (namely, the samples were put directly on ice after mixing with non-radioactive 265 Data analysis. Gel bands were quantified using an in-house custom software and the fraction 315 PEGylated and fraction of blocked cysteine were computed. Each data point of AMS-blocking 316 was normalized to the NEM and water controls, corresponding to 100% and 0% blocking, 317 respectively. When applicable, the data were fitted using nonlinear regression to the formula 318 (Y(t)=Y0 + (YPlateau-Y0)x(1-e (-kt) )). Where Y(t) is the fraction of blocked Cys at time t, Y0 is the 319 fraction blocked upon an infinitesimally short reaction time with AMS, k is the rate constant 320 (corresponding to k1 in Fig. 2b) and t is the time. Fitting was done using the Graphpad Prism 321 software. 322 323 Drug resistance assay. A single colony from a fresh transformation of BL21(DE3) DemrE::kana
R , 324
DmdtJI::Cm R , harboring the indicated pET plasmids was grown overnight in LB medium 325 supplemented with 100 µg/ml ampicillin. The culture was then back-diluted 1:50 into the same 326 medium and grown at 37°C to mid-logarithmic phase (OD600 ~0.5). Five 10-fold serial dilutions 327 were then prepared from the cultures, with the highest density being of OD 0.1. The serial 328 dilution was spotted (3.5 µL) on LB-agar-ampicillin plates containing 30 mM bis-tris-propane pH 329 7.0 and drug ethidium bromide (50 µg/mL). Identical plates without ethidium bromide served 330 as control. The plates were allowed to grow for one or two nights at 37°C. 331 332
Analysis of disulfides and their effect on cysteine blocking. Cultures (5 mL) of BL21(DE3) 333
DemrE::kana R DmdtJI::Cm R or BL21(DE3) DdsbA::kana R harboring a plasmids encoding 334
EmrE[Nin/Cin-P 3 C] were grown and radiolabeled as described above, except that for the 'plus 335 TCEP' condition cells received 1 mM TCEP together with the radiolabeled [
35 S]Met. After chilling 336 the cultures on ice, 4 mL were used to measure Cys blocking in whole cells as described above 337 (using 20 min blocking time). The remaining 1 mL was used to detect disulfide-bonded dimers 338 as follows. Samples were washed once by centrifugation at 4°C, 3,200 x g, 5 min and 339 resuspension in 1 mL of 150 mM NaCl, 30 mM Tris-HCl pH 7.5, 5 mM MgSO4. Cells were 340 pelleted again and resuspended in 1 mL of the same buffer. NEM (100 µL, 0.2 M) was added 341 and the samples were allowed to react at 30 °C with gentle mixing for 20 min. Samples were 342 13 then washed twice by centrifugation at 4°C, 10,000 x g, 1 min and resuspension in 1 mL of 150 343 mM NaCl, 30 mM Tris-HCl pH 7.5, 5 mM MgSO4. The cells were then pelleted again and 344 resuspended in 150 µL of Lysozyme buffer (150 mM NaCl, 30 mM Tris-HCl pH 8, 10 mM EDTA, 345 cOmplete protease inhibitor (Roche), 1 mg/ml lysozyme, containing no TCEP) and frozen in -346 20°C for at least 20 min. Cells were disrupted by thawing at 25°C for 5 min followed by shaking 347 at 37°C for 10 min. Then 0.9 ml of DNase solution (15 mM MgSO4, 10 µg/mL DNase I, 0.5 mM 348 PMSF, containing no TCEP) was added and the samples were allowed to shake at 37°C for 10 349 min before transferring them to ice. Crude membranes were collected by centrifugation at 4°C, 350 20,000 x g, 20 min and the pellet was resuspended in 50 µL of 150 mM NaCl, 30 mM Tris-HCl 351 pH 7.5. Non-reducing 5x sample buffer (120 mM Tris-HCl pH 6.8, 50% glycerol, 2% SDS, and 352 0.1% bromophenol blue, 17.5 µL per sample) was added to all samples and they were then 353 divided to two tubes, with or without 100 mM DTT. Topology assay using cysteine accessibility a. Schematic description of the assay. Note that the EmrE mutants used in the assay typically contain a single Cys, unlike the two cysteines shown in the example. This depiction is shown here to demonstrate the difference between a periplasmic and cytosolic Cys. Brifely, a sulfhydryl reagent that cannot cross the cytoplasmic membrane, 4-acetamido-4ʹ-maleimidylstilbene-2,2ʹ-disulfonic acid (AMS), is added to whole cells to block any cysteines that are accessible from the periplasm. Subsequently, the membrane is disrupted and another reagent, maleimide-polyethylene glycol (mal-PEG), is added to derivatize any unblocked cysteines. Cytosolic cysteines remain reactive to mal-PEG, which increases the mass of the protein by 5 kDa. In contrast, periplasmic cysteines are blocked by AMS and cannot subsequently be PEGylated. As a control, a membrane-permeable reagent, Nethylmaleimide (NEM), is used in the blocking step instead of AMS, to confirm that the test cysteines are in a solvent-exposed position that can be blocked from either the cytosol or the periplasm. b. Analyzing the Cys accessibility of EmrE-T28C, in the dual topology protein or in mutants engineered to a single topology, either N in /C in or N out /C out . The predicted localization of the Cys in position 28 relative to the inner membrane is shown above the gel. For each construct, lanes 1,2 and 3 show the amount of PEGylation remaining after blocking the Cys in whole cells using NEM, AMS and water (as control), respectively. NEM blocks all cysteines, whereas AMS blocks only periplasmic ones. b. The correlation between ln(k 1 ) (see Fig. 2b ) and ΔG app implies that the Arrhenius activation energy E a is proportional to ΔG app . The equation below is the Arrhenius equation, which indicates a linear relationship between the activation energy (E a ) and ln(k) (T,R and A are temperature, the gas constant and the preexponential factor, respectively). Error bars indicate standard deviation of independent experiments (n = 3).
c. Energy diagrams for the activation energy (E a ) for the transition from the transmembrane to the periplasmically exposed state of TMH1. TS, transition state. 
